Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity PYC THERAPEUTICS LIMITED ABN/ARBN Financial year ended: 48 098 391 961 30 JUNE 2026 ...
Appendix 4G
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4g-241
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Earlier from PYC Therapeutics
- 2026 Annual Report to Shareholders
- Appendix 4E
- Notification regarding unquoted securities - PYC
- Investor Webinar
- Change of Director's Interest Notice
Later from PYC Therapeutics
- 2026 Corporate Governance Statement
- PKD - Presentation of Clinical Safety Data
- Ceasing to be a substantial holder
- ADOA Program - Data Presentation
- Investor Webinar Presentation Q3 2026
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics